drugset / Trial / NCT00581425
Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)
NaSingle-groupOpen-labelTreatment
Summary
A trial to see if BCC excluding the scalp and face can be treated successfully with a combination therapy of Intron-A and Aldara.
Timeline
- Start
- 2007-12
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Imiquimod | Other / unclassified | — | — |
| Subject | Interferon-alpha | Protein / enzyme biologic | — | — |